Results 21 to 30 of about 26,342,767 (265)

Performance Characteristics of Seven Automated CA 15-3 Assays [PDF]

American Journal of Clinical Pathology, 2006
Measurements of serum cancer antigen (CA) 15-3 are used to monitor tumor recurrence and treatment of advanced disease. We evaluated the performance characteristics, including limit of detection, linearity, method comparison, and reference intervals, of 7 automated methods for CA 15-3, including the Access 2 (Beckman Coulter, Brea, CA), ADVIA Centaur ...
Patricia R, Slev, Mindy L, Rawlins, William L, Roberts   +2 more
openaire   +2 more sources

Tumor Markers in Dogs with Mammary Gland Tumors

Acta Veterinaria, 2023
The aim of this study was to determine and compare values of carcinoembryonic antigen (CEA) and cancer antigen (CA 15-3) in 50 bitches with mammary tumors and 150 clinically healthy dogs.
Valencakova Alexandra, Kiselova-Bilekova Beata, Figurova Maria, Hornak Slavomir, Hornakova Lubica   +4 more
doaj   +1 more source

Multicenter evaluation of the Abbott IMx CA 15-3 assay [PDF]

Clinical Chemistry, 1996
Abstract We describe a new fully automated procedure for the quantitative measurement of CA 15-3: the microparticle enzyme immunoassay (MEIA) technology developed by Abbott Labs. for the IMx automated immunoassay analyzer. The new IMx CA 15-3 test uses two mouse monoclonal antibodies, 115D8 and DF3.
G J, van Kamp, G G, Bon, R A, Verstraeten, D, Lynch, M, Krikau, J, Flückiger, A, Ruibal, P, Kenemans   +7 more
openaire   +2 more sources

Značenje tumorskog markera Ca 15-3 [PDF]

, 2004
In the postoperative course of breast tumor treatment, along with regular ultrasound and radiological assessments, measurements of tumor marker CA 15-3 levels are also used.
Juzbašić, Stjepan, Lesar, Miroslav, Orešić, Tomislav, Stanec, Mladen, Roth, Andrej   +4 more
core   +2 more sources

Tissue ELISA and Serum Amperometric Magnetoimmunosensor of ECD-HER2 In Stratifying Subtyping of Egyptian Woman Breast Cancers [PDF]

Zagazig University Medical Journal
Background: Detection of HER2 extracellular domain (ECD) amperometric magnetoimmunosensor (AM) investigated on raw cell lysates, intact breast cancer cells, and commercial and healthy sera except on patients' samples.
Sameh Nakhla, Zynab Elwafe, Ahmed Saad Saad, Tarek Aref, Noha Ragab, inas elbadry, Unai Eletxigerra Eletxigerra, Susana Campuzano, Jesus Martínez-Perdiguero, Santos Merino Merino, José M. Pingarrón, Salah Abdelmoneim, Eman El-Abd   +12 more
doaj   +1 more source

Clinical evaluation comparing AxSYM CA 15-3, IMx CA 15-3 and Truquant BRTM RIA.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 1999
A retrospective clinical study was conducted to compare results obtained by AxSYM(R) CA 15-3(TM), IMx(R) CA 15-3 and Truquant(R) BRTM RIA using surplus serum specimens from healthy volunteers and patients with benign and malignant diseases. Linear regression analysis of AxSYM and IMx CA 15-3 versus Truquant BR RIA for specimens with results 0-250 U/ml ...
D M, Lynch, P E, Rogers, J C, Love, M J, Salkas, K A, Skarphol, M E, Gross, M G, Lu, V H, Petrides, D J, Bruzek, J L, Cox, K A, Jones, C A, Kelley, D W, Chan   +12 more
openaire   +2 more sources

Investigation of a Stable Interaction of Levothyroxine with AFP Through Molecular Modelling

Cumhuriyet Science Journal
Thyroid dysfunctions are common all over the world, and accordingly, the use of thyroid drugs has increased. Incorrect measurement of tumor markers may lead to missed cases of cancer.
Emel Akbaba, Deniz Karataş, Ataman Gönel, Ezgi Soylu, Beste Kiraz, Yusur Ammar Almahdi   +5 more
doaj   +1 more source

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients

BMC Cancer, 2012
Background Mucin-1 is known to be over-expressed by various human carcinomas and is shed into the circulation where it can be detected in patient’s serum by specific anti-Mucin-1 antibodies, such as the tumour marker assays CA 15–3 and CA 27.29.
Engelstaedter Verena, Heublein Sabine, Schumacher Anamur Lan, Lenhard Miriam, Engelstaedter Helen, Andergassen Ulrich, Guenthner-Biller Margit, Kuhn Christina, Rack Brigitte, Kupka Markus, Mayr Doris, Jeschke Udo   +11 more
doaj   +1 more source

Gene expression of Epithelial Membrane Protein 2 gene and β1-Integrin gene in patients with breast cancer

Biochemistry and Biophysics Reports, 2020
Background: Breast cancer is the most common invasive cancer and the leading cause of cancer death in women. The function of over a thousand genes is reported as affected by genetic modifications in breast cancer. Objectives: To study the gene expression
Samah EL-Ghlban, Elsayed Saber AbouElnour, Abd El-Monem Abd El- Kader EL- Torgoman, Saeed Mohamed Saeed Abu Elabas   +3 more
doaj   +1 more source

Practical application of the CA-62 tumor marker in the initial diagnosis of oncological disease of epithelial origin: assistance to the doctor in interpreting the results

Consilium Medicum, 2023
Aim. Demonstration the possibility of practical application of the highly sensitive tumor marker CA-62 in the initial diagnosis in asymptomatic patients with suspected cancer and/or the presence of pathological changes in instrumental studies, as well as
Janneta R. Tcherkassova, Sergei A. Tsurkan, Anna I. Prostyakova, Nikolai V. Suganov, Alexander M. Boroda, Albina I. Khamitova, Alexander P. Roytman   +6 more
doaj   +1 more source